Hi everyone,
I am using the Callaway & Sant’Anna (2021) DID estimator (csdid) in a staggered adoption setting. I only have not-yet-treated as my control group. After examining the (g,t) cells, I noticed that for some cohorts, particularly later adopters, the number of not-yet-treated units becomes very small (sometimes only 1–3 observations).
My ATT estimate is unusually large and unstable, which makes me concerned about weak support.
My questions are:
Many thanks.
I am using the Callaway & Sant’Anna (2021) DID estimator (csdid) in a staggered adoption setting. I only have not-yet-treated as my control group. After examining the (g,t) cells, I noticed that for some cohorts, particularly later adopters, the number of not-yet-treated units becomes very small (sometimes only 1–3 observations).
My ATT estimate is unusually large and unstable, which makes me concerned about weak support.
My questions are:
- When the not-yet-treated comparison group is extremely small, should those (g,t) cells be considered unreliable?
- Is it acceptable practice to trim cells based on a minimum control group size (e.g., requiring at least 5–10 controls)?
- Is csdid still appropriate, or should alternative approaches such as Synthetic DID be considered under this occasion?
Many thanks.

Comment